Nisoxetine and amphetamine share discriminative stimulus properties in mice. 1983

A M Snoddy, and R E Tessel

The interaction of amphetamine with noradrenergic neurons could mediate a portion of the drug's discriminative stimulus properties. To test this hypothesis, mice were trained to discriminate 1.0 or 3.2 mg/kg amphetamine, 32 mg/kg of the selective norepinephrine uptake inhibitor, nisoxetine, or 32 mg/kg nisoxetine + 1.0 mg/kg amphetamine from saline. Differential drug- or saline-appropriate responding was determined using a two photocell-beam procedure with beam interruption as the operant. Reinforcement (5-sec access to evaporated milk) was presented on a fixed-ratio 20 (FR-20) schedule. Mice trained to discriminate 1.0 mg/kg amphetamine from saline generalized to nisoxetine (32 mg/kg) alone and to doses of 0.56 mg/kg amphetamine and above but not to lower doses unless pretreated with nisoxetine (20 or 32 mg/kg). Mice trained to discriminate nisoxetine (32 mg/kg) from saline generalized to 0.56, 1.0 and 3.2 mg/kg amphetamine and generalized to all amphetamine doses when pretreated with nisoxetine (32 mg/kg). Mice trained to discriminate the drug combination from saline generalized to nisoxetine (32 mg/kg) alone, and to 3.2 mg/kg amphetamine tested alone, to 0.56 mg/kg of amphetamine or above when the lower dose of nisoxetine (20 mg/kg) was used, and to all test doses of amphetamine with nisoxetine (32 mg/kg) pretreatment. Mice trained to discriminate 3.2 mg/kg amphetamine from saline generalized to no test dose of amphetamine following either saline or nisoxetine (32 mg/kg) pretreatment. Testing with several doses of pentobarbital (1.0, 3.0, 10.0 and 18.0 mg/kg) resulted in saline-appropriate responding regardless of training group.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D011437 Propylamines Derivatives of propylamine (the structural formula NH2CH2CH2CH3).
D004192 Discrimination, Psychological Differential response to different stimuli. Discrimination, Psychology,Psychological Discrimination
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005473 Fluoxetine The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Fluoxetin,Fluoxetine Hydrochloride,Lilly-110140,N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,Prozac,Sarafem,Lilly 110140,Lilly110140
D000661 Amphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine

Related Publications

A M Snoddy, and R E Tessel
December 1992, Pharmacology, biochemistry, and behavior,
A M Snoddy, and R E Tessel
March 1991, Pharmacology, biochemistry, and behavior,
A M Snoddy, and R E Tessel
October 1982, Pharmacology, biochemistry, and behavior,
A M Snoddy, and R E Tessel
January 1980, Psychopharmacology,
A M Snoddy, and R E Tessel
January 1986, Medicinal research reviews,
A M Snoddy, and R E Tessel
January 1991, NIDA research monograph,
A M Snoddy, and R E Tessel
September 1976, Archives internationales de pharmacodynamie et de therapie,
A M Snoddy, and R E Tessel
March 1981, Neuropharmacology,
A M Snoddy, and R E Tessel
August 1992, Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology,
A M Snoddy, and R E Tessel
January 1974, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!